The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rapid Diagnostic Kits-Global Market Insights and Sales Trends 2024
Synopsis
The rapid diagnostic kits are used to detect or diagnose a variety of infections, diseases, and illnesses that a patient may have. In addition, these kits can accurately diagnose diseases such as malaria, as well as diseases such as diabetes and pregnancy.
The global Rapid Diagnostic Kits market size is expected to reach US$ 24820 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Rapid Diagnostic Kits in various end use industries. The expanding demands from the Hospitals and Clinical Testing, Home Testing, Veterinary Testing and Other, are propelling Rapid Diagnostic Kits market. Lateral Flow Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agglutination Assays segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rapid Diagnostic Kits, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rapid Diagnostic Kits market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rapid Diagnostic Kits market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rapid Diagnostic Kits sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rapid Diagnostic Kits covered in this report include Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX and McKesson, etc.
The global Rapid Diagnostic Kits market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alfa Scientific Designs
Artron Laboratories
BD
Meridian Bioscience
ACON Laboratories
Creative Diagnostics
BTNX
McKesson
Roche
Zoetis
BioMerieux
Thermo Fisher Scientific
Siemens Healthcare
Global Rapid Diagnostic Kits market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rapid Diagnostic Kits market, Segment by Type:
Lateral Flow Test
Agglutination Assays
Flow Through
Solid Phase
Global Rapid Diagnostic Kits market, by Application
Hospitals and Clinical Testing
Home Testing
Veterinary Testing
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rapid Diagnostic Kits companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The rapid diagnostic kits are used to detect or diagnose a variety of infections, diseases, and illnesses that a patient may have. In addition, these kits can accurately diagnose diseases such as malaria, as well as diseases such as diabetes and pregnancy.
The global Rapid Diagnostic Kits market size is expected to reach US$ 24820 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Rapid Diagnostic Kits in various end use industries. The expanding demands from the Hospitals and Clinical Testing, Home Testing, Veterinary Testing and Other, are propelling Rapid Diagnostic Kits market. Lateral Flow Test, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Agglutination Assays segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rapid Diagnostic Kits, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rapid Diagnostic Kits market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rapid Diagnostic Kits market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rapid Diagnostic Kits sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rapid Diagnostic Kits covered in this report include Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX and McKesson, etc.
The global Rapid Diagnostic Kits market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Alfa Scientific Designs
Artron Laboratories
BD
Meridian Bioscience
ACON Laboratories
Creative Diagnostics
BTNX
McKesson
Roche
Zoetis
BioMerieux
Thermo Fisher Scientific
Siemens Healthcare
Global Rapid Diagnostic Kits market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rapid Diagnostic Kits market, Segment by Type:
Lateral Flow Test
Agglutination Assays
Flow Through
Solid Phase
Global Rapid Diagnostic Kits market, by Application
Hospitals and Clinical Testing
Home Testing
Veterinary Testing
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Rapid Diagnostic Kits companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Rapid Diagnostic Kits
1.1 Rapid Diagnostic Kits Market Overview
1.1.1 Rapid Diagnostic Kits Product Scope
1.1.2 Rapid Diagnostic Kits Market Status and Outlook
1.2 Global Rapid Diagnostic Kits Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Rapid Diagnostic Kits Market Size by Region (2018-2029)
1.4 Global Rapid Diagnostic Kits Historic Market Size by Region (2018-2023)
1.5 Global Rapid Diagnostic Kits Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Rapid Diagnostic Kits Market Size (2018-2029)
1.6.1 North America Rapid Diagnostic Kits Market Size (2018-2029)
1.6.2 Europe Rapid Diagnostic Kits Market Size (2018-2029)
1.6.3 Asia-Pacific Rapid Diagnostic Kits Market Size (2018-2029)
1.6.4 Latin America Rapid Diagnostic Kits Market Size (2018-2029)
1.6.5 Middle East & Africa Rapid Diagnostic Kits Market Size (2018-2029)
2 Rapid Diagnostic Kits Market by Type
2.1 Introduction
2.1.1 Lateral Flow Test
2.1.2 Agglutination Assays
2.1.3 Flow Through
2.1.4 Solid Phase
2.2 Global Rapid Diagnostic Kits Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Rapid Diagnostic Kits Historic Market Size by Type (2018-2023)
2.2.2 Global Rapid Diagnostic Kits Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Rapid Diagnostic Kits Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Rapid Diagnostic Kits Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Rapid Diagnostic Kits Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Rapid Diagnostic Kits Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Rapid Diagnostic Kits Revenue Breakdown by Type (2018-2029)
3 Rapid Diagnostic Kits Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinical Testing
3.1.2 Home Testing
3.1.3 Veterinary Testing
3.1.4 Other
3.2 Global Rapid Diagnostic Kits Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Rapid Diagnostic Kits Historic Market Size by Application (2018-2023)
3.2.2 Global Rapid Diagnostic Kits Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Rapid Diagnostic Kits Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Rapid Diagnostic Kits Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Rapid Diagnostic Kits Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Rapid Diagnostic Kits Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Rapid Diagnostic Kits Revenue Breakdown by Application (2018-2029)
4 Rapid Diagnostic Kits Competition Analysis by Players
4.1 Global Rapid Diagnostic Kits Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rapid Diagnostic Kits as of 2022)
4.3 Date of Key Players Enter into Rapid Diagnostic Kits Market
4.4 Global Top Players Rapid Diagnostic Kits Headquarters and Area Served
4.5 Key Players Rapid Diagnostic Kits Product Solution and Service
4.6 Competitive Status
4.6.1 Rapid Diagnostic Kits Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Rapid Diagnostic Kits Products, Services and Solutions
5.1.4 Abbott Laboratories Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Alfa Scientific Designs
5.2.1 Alfa Scientific Designs Profile
5.2.2 Alfa Scientific Designs Main Business
5.2.3 Alfa Scientific Designs Rapid Diagnostic Kits Products, Services and Solutions
5.2.4 Alfa Scientific Designs Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.2.5 Alfa Scientific Designs Recent Developments
5.3 Artron Laboratories
5.3.1 Artron Laboratories Profile
5.3.2 Artron Laboratories Main Business
5.3.3 Artron Laboratories Rapid Diagnostic Kits Products, Services and Solutions
5.3.4 Artron Laboratories Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.3.5 BD Recent Developments
5.4 BD
5.4.1 BD Profile
5.4.2 BD Main Business
5.4.3 BD Rapid Diagnostic Kits Products, Services and Solutions
5.4.4 BD Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.4.5 BD Recent Developments
5.5 Meridian Bioscience
5.5.1 Meridian Bioscience Profile
5.5.2 Meridian Bioscience Main Business
5.5.3 Meridian Bioscience Rapid Diagnostic Kits Products, Services and Solutions
5.5.4 Meridian Bioscience Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.5.5 Meridian Bioscience Recent Developments
5.6 ACON Laboratories
5.6.1 ACON Laboratories Profile
5.6.2 ACON Laboratories Main Business
5.6.3 ACON Laboratories Rapid Diagnostic Kits Products, Services and Solutions
5.6.4 ACON Laboratories Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.6.5 ACON Laboratories Recent Developments
5.7 Creative Diagnostics
5.7.1 Creative Diagnostics Profile
5.7.2 Creative Diagnostics Main Business
5.7.3 Creative Diagnostics Rapid Diagnostic Kits Products, Services and Solutions
5.7.4 Creative Diagnostics Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.7.5 Creative Diagnostics Recent Developments
5.8 BTNX
5.8.1 BTNX Profile
5.8.2 BTNX Main Business
5.8.3 BTNX Rapid Diagnostic Kits Products, Services and Solutions
5.8.4 BTNX Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.8.5 BTNX Recent Developments
5.9 McKesson
5.9.1 McKesson Profile
5.9.2 McKesson Main Business
5.9.3 McKesson Rapid Diagnostic Kits Products, Services and Solutions
5.9.4 McKesson Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.9.5 McKesson Recent Developments
5.10 Roche
5.10.1 Roche Profile
5.10.2 Roche Main Business
5.10.3 Roche Rapid Diagnostic Kits Products, Services and Solutions
5.10.4 Roche Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Recent Developments
5.11 Zoetis
5.11.1 Zoetis Profile
5.11.2 Zoetis Main Business
5.11.3 Zoetis Rapid Diagnostic Kits Products, Services and Solutions
5.11.4 Zoetis Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.11.5 Zoetis Recent Developments
5.12 BioMerieux
5.12.1 BioMerieux Profile
5.12.2 BioMerieux Main Business
5.12.3 BioMerieux Rapid Diagnostic Kits Products, Services and Solutions
5.12.4 BioMerieux Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.12.5 BioMerieux Recent Developments
5.13 Thermo Fisher Scientific
5.13.1 Thermo Fisher Scientific Profile
5.13.2 Thermo Fisher Scientific Main Business
5.13.3 Thermo Fisher Scientific Rapid Diagnostic Kits Products, Services and Solutions
5.13.4 Thermo Fisher Scientific Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.13.5 Thermo Fisher Scientific Recent Developments
5.14 Siemens Healthcare
5.14.1 Siemens Healthcare Profile
5.14.2 Siemens Healthcare Main Business
5.14.3 Siemens Healthcare Rapid Diagnostic Kits Products, Services and Solutions
5.14.4 Siemens Healthcare Rapid Diagnostic Kits Revenue (US$ Million) & (2018-2023)
5.14.5 Siemens Healthcare Recent Developments
6 North America
6.1 North America Rapid Diagnostic Kits Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Rapid Diagnostic Kits Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Rapid Diagnostic Kits Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Rapid Diagnostic Kits Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Rapid Diagnostic Kits Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Rapid Diagnostic Kits Market Dynamics
11.1 Rapid Diagnostic Kits Industry Trends
11.2 Rapid Diagnostic Kits Market Drivers
11.3 Rapid Diagnostic Kits Market Challenges
11.4 Rapid Diagnostic Kits Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
